Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(6S)-6-cyclopentyl–[...]-pyran–one is a synthetic small molecule with a pyranone core and specific stereochemistry. It is listed in pharmaceutical compound libraries such as ZINC15 and has been identified as a potential endocrine-disrupting compound. There is no evidence of clinical use or advanced development status; it appears to be an experimental or screening-stage molecule. Its mechanism of action and therapeutic indication are not established in the literature or major drug databases[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (6S)-6-cyclopentyl-6-[2-(3-fluoro-4-isopropoxyphenyl)ethyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one.